Novel Biomarkers of Coronary Microvascular Disease
- 13 June 2016
- journal article
- Published by Taylor & Francis in Future Cardiology
- Vol. 12 (4) , 497-509
Abstract
Coronary microvascular disease in the absence of myocardial diseases has traditionally been diagnosed through coronary reactivity testing in the cardiac catheterization laboratory. Compared with invasive procedures, blood-based biomarkers may have reduced cost, less risk of physical harm and greater accessibility, making them ideal for an outpatient management strategy. There are a variety of biomarkers available with potential utility in the management of microvascular disease; however, none have yet been extensively validated or established in this clinical patient population.Keywords
Funding Information
- National Research Service Awards (5T32HL007745)
This publication has 86 references indexed in Scilit:
- Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health InitiativeCirculation, 2012
- Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular eventsEuropean Heart Journal, 2011
- Plasma asymmetric dimethylarginine and l-arginine levels in Chinese patients with essential hypertension without coronary artery diseaseJournal of Cardiovascular Disease Research, 2011
- Inflammation is Related to Coronary Flow Reserve Detected by Positron Emission Tomography in Asymptomatic Male TwinsJACC, 2011
- Inflammation in AtherosclerosisJACC, 2009
- Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Carotid intima–media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginineAtherosclerosis, 2009
- Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery DiseaseArchives of internal medicine (1960), 2009
- Are Low Total Serum Antioxidant Status and Elevated Levels of C-Reactive Protein and Monocyte Chemotactic Protein-1 Associated With Cardiac Syndrome X?Circulation Journal, 2005
- Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteriesAmerican Heart Journal, 1998